Other

Unrealized Gain (Loss) on Securities

Revolution Medicines, Inc. Unrealized Gain (Loss) on Securities decreased by 3282.6% to -$3.85M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1097.7%, from $386.00K to -$3.85M. Over 3 years (FY 2021 to FY 2025), Unrealized Gain (Loss) on Securities shows an upward trend with a 57.3% CAGR.

Analysis

StatementIncome Statement
SectionOther
First reportedQ1 2021
Last reportedQ1 2026May 6, 2026
Metric ID: cop_unrealized_gain_loss_on_securities

Historical Data

19 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value-$123.00K-$123.00K-$123.00K$581.00K$581.00K$581.00K$581.00K$1.22M-$695.00K$380.00K$1.42M-$1.74M-$665.00K$5.68M$386.00K-$405.00K$1.81M$121.00K-$3.85M
QoQ Change—+0.0%+0.0%+572.4%+0.0%+0.0%+0.0%+110.7%-156.8%+154.7%+272.4%-223.1%+61.8%+953.4%-93.2%-204.9%+547.9%-93.3%<-999%
YoY Change————+572.4%+572.4%+572.4%+110.7%-219.6%-34.6%+143.5%-242.3%+4.3%>999%+122.2%+39.1%-68.0%—<-999%
Range-$3.85M – $5.68M
CAGR+115.0%
Avg YoY Growth+133.4%
Median YoY Growth+74.9%
Current Streak2 quarters decline

Frequently Asked Questions

What is Revolution Medicines, Inc.'s unrealized gain (loss) on securities?
Revolution Medicines, Inc. (RVMD) reported unrealized gain (loss) on securities of -$3.85M in Q1 2026.
How has Revolution Medicines, Inc.'s unrealized gain (loss) on securities changed year-over-year?
Revolution Medicines, Inc.'s unrealized gain (loss) on securities decreased by 1097.7% year-over-year, from $386.00K to -$3.85M.
What is the long-term trend for Revolution Medicines, Inc.'s unrealized gain (loss) on securities?
Over 3 years (2021 to 2025), Revolution Medicines, Inc.'s unrealized gain (loss) on securities has grown at a 57.3% compound annual growth rate (CAGR), from -$492.00K to $1.92M.